Stock futures edged lower on Friday as President Donald Trump’s decision to extend a critical deadline for strikes against Iranian energy infrastructure failed to assuage investor anxiety. The ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings inline with expectations. Reported EPS is $-2.475 EPS, expectations were ...

Bionano Genomics, Inc. reports earnings inline with expectations. Reported EPS is $-2.475 EPS, expectations were $-2.475. Operator: Good day, and welcome to the Bionano Genomics, Inc. Fourth Quarter ...

Bionano Genomics Inc. stock grades by Barron's. View BNGO fundamental and sentiment analysis powered by MarketGrader.

Management attributed revenue softness to supply constraints in consumables, not demand weakness, and indicated expected recovery as manufacturing delays are resolved. There is a strategic emphasis on ...

Image source: The Motley Fool. Management attributed revenue softness to supply constraints in consumables, not demand weakness, and indicated expected recovery as manufacturing delays are resolved.

Stocks slid again as oil prices spiked on Friday, as the major indexes fell for a third-straight week. The Dow Jones Industrial Average fell 119 points, or 0.3%. The S&P 500 was down 0.6%. The Nasdaq ...

When a stock’s share price gets excessively high, purchasing even one share may become too costly for small investors. While stock splits do not create inherent value, they often act as bullish ...

David Zaslav, president and CEO of Warner Bros. Discovery, filed to sell just over $114 million worth of stock in the company. His sale of the shares comes less than a week after WBD clinched a deal ...

UBS downgraded U.S. equities, saying factors that powered years of outperformance are starting to fade. The dollar risk is a central concern as the firm sees "asymmetric structural downside risks" to ...